pembrolizumab,alrizomadlin
merck,ascentage pharmaceuticals
['ascent', 'solid tumor', 'alrizomadlin', 'apg-115', 'pembro', 'ascentage pharma', 'ascentage']
asco 2022 | ascentage pharma releases updated results demonstrating the therapeutic potential of alrizomadlin (apg-115) plus pembrolizumab in patients with solid tumors who progressed on immunotherapies 
A Cure In Sight is a non-profit organization founded to raise Ocular Melanoma awareness and to help OM patients find/pay for the treatments that they need.